Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Feb 28, 2019
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Purchase
Common Stock
2019-02-26$2.02/sh+10,000$20,210→ 20,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.995 to 2.08 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.